IL17A and cancer: Although there is currently no direct evidence that clearly demonstrates a specific interaction between UBE2T and the IL-17 signaling pathway, considering the broad role of ubiquitination in signaling pathways, UBE2T may indirectly participate in the regulation of inflammatory responses and its role in cancer by modulating key components of the IL-17 signaling pathway.